Chronic Administration of Losartan, an Angiotensin II Receptor Antagonist, is not Effective in Reducing Portal Pressure in Patients with Preascitic Cirrhosis-Reference-Cited by-同舟云学术

Chronic Administration of Losartan, an Angiotensin II Receptor Antagonist, is not Effective in Reducing Portal Pressure in Patients with Preascitic Cirrhosis

Published:2004-02 Issue:2 Volume:99 Page:390-394
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:
Short-container-title:Am J Gastroenterol

Author:

Tripathi Dhiraj,Therapondos George,Lui Hock F,Johnston Neil,Webb David J,Hayes Peter C

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Primary prophylaxis of variceal bleeding in cirrhosis

2. A drug therapy for the prevention of variceal haemorrhage

3. The treatment of portal hypertension: A meta-analytic review*1

4. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis;Beilstein Journal of Nanotechnology;2024-08-23

2. The Renin–Angiotensin System in Liver Disease;International Journal of Molecular Sciences;2024-05-27

3. Close Relationship between Systemic Arterial and Portal Venous Pressure in an Animal Model with Healthy Liver;International Journal of Molecular Sciences;2023-06-09

4. Theranostic Application of Nanoparticulated System: Present and Future Prospects;Materials Research Foundations;2019-04-20

5. Carbonation of hybrid concrete with high blast furnace slag content and its impact on structural steel corrosion;Materiales de Construcción;2019-02-13